Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2013, Article ID 345198, 12 pages
http://dx.doi.org/10.1155/2013/345198
Review Article

Biological Aspects of Emerging Benzothiazoles: A Short Review

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard, Hamdard University, New Delhi 110062, India

Received 10 May 2013; Accepted 29 June 2013

Academic Editor: Gabriel Navarrete-Vazquez

Copyright © 2013 Ruhi Ali and Nadeem Siddiqui. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Wang, X. Shi, J. Wang et al., “Synthesis, structure-activity relationships and preliminary antitumor evaluation of benzothiazole-2-thiol derivatives as novel apoptosis inducers,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 4, pp. 1097–1101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Kumbhare, T. Dadmal, U. Kosurkar, V. Sridhar, and J. V. Rao, “Synthesis and cytotoxic evaluation of thiourea and N-bis-benzothiazole derivatives: a novel class of cytotoxic agents,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 1, pp. 453–455, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Jin, B. Song, G. Zhang et al., “Synthesis, X-ray crystallographic analysis, and antitumor activity of N-(benzothiazole-2-yl)-1-(fluorophenyl)-O,O-dialkyl-α-aminophosphonates,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 6, pp. 1537–1543, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Saeed, N. Rashid, P. G. Jones, M. Ali, and R. Hussain, “Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents,” European Journal of Medicinal Chemistry, vol. 45, no. 4, pp. 1323–1331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Havrylyuk, L. Mosula, B. Zimenkovsky, O. Vasylenko, A. Gzella, and R. Lesyk, “Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety,” European Journal of Medicinal Chemistry, vol. 45, no. 11, pp. 5012–5021, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. V. R. Solomon, C. Hu, and H. Lee, “Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 21, pp. 7585–7592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Kamal, K. S. Reddy, M. N. Khan et al., “Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole-pyrrolo[2,1-c][1,4]benzodiazepine conjugates,” Bioorganic and Medicinal Chemistry, vol. 18, no. 13, pp. 4747–4761, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Prabhu, T. Panneerselvam, C. S. Shastry, A. Sivakumar, and S. Pande, “Synthesis and anticancer evaluation of 2-phenyl thiaolidinone substituted 2-phenyl benzothiazole-6-carboxylic acid derivatives,” Journal of Saudi Chemical Society, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Caputo, M. L. Calabro, N. Micale et al., “Synthesis of benzothiazole derivatives and their biological evaluation as anticancer agents,” Medicinal Chemistry Research, vol. 21, pp. 2644–2651, 2012. View at Google Scholar
  10. J. Chen, L. Qian, Y. Shen, L. Chen, and K. Zheng, “A QSAR study and molecular design of benzothiazole derivatives as potent anticancer agents,” Science in China B, vol. 51, no. 2, pp. 111–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. G. Mortimer, G. Wells, J. Crochard et al., “Antitumor benzothiazoles. 26.1 2-(3,4-dimethoxyphenyl)-5- fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines,” Journal of Medicinal Chemistry, vol. 49, no. 1, pp. 179–185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. D. T. Oanh, H. V. Hai, S. Park et al., “Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 24, pp. 7509–7512, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. H. L. Kok, R. Gambari, CH. H. Chui et al., “Synthesis and anti-cancer activity of benzothiazole containing phthalimide on human carcinoma cell lines,” Bioorganic and Medicinal Chemistry, vol. 16, no. 7, pp. 3626–3631, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. K. Sahu, P. K. Sahu, J. Lal, D. Thavaselvam, and D. Agarwal, “A facile green synthesis and in vitro antimicrobial activity 4H-pyrimido[2,1-b][1,3]benzothiazole derivatives using aluminum trichloride under solvent free conditions,” Medicinal Chemistry Research, vol. 21, no. 11, pp. 3826–3834, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Amir, S. A. Javed, and M. Zaheen Hassan, “Synthesis and antimicrobial activity of pyrazolinones and pyrazoles having benzothiazole moiety,” Medicinal Chemistry Research, vol. 21, no. 7, pp. 1261–1270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. T. Asundaria and K. C. Patel, “Synthesis, characterization and antimicrobial activity of thiazole, benzothiazole and pyrimidine derivatives bearing sydnone moieties,” Pharmaceutical Chemistry Journal, vol. 45, no. 12, pp. 725–731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Bolelli, I. Yalcin, T. Ertan-Bolelli et al., “Synthesis of novel 2-[4-(4-substitutedbenzamido/phenylacetamido)phenyl]benzothiazoles as antimicrobial agents,” Medicinal Chemistry Research, vol. 21, no. 11, pp. 3818–3825, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. P. K. Sharma, M. Kumar, and V. Mohan, “Synthesis and antimicrobial activity of 2H-pyrimido[2,1-b]benzothiazol-2- ones,” Research on Chemical Intermediates, vol. 36, no. 8, pp. 985–993, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Sheng, J. Zhu, W. Zhang et al., “3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors,” European Journal of Medicinal Chemistry, vol. 42, no. 4, pp. 477–486, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. B. S. Soni, M. Ranawat, R. Sharma, A. Bhandari, and S. Sharma, “Synthesis and evaluation of some new benzothiazole derivatives as potential antimicrobial agents,” European Journal of Medicinal Chemistry, vol. 45, no. 7, pp. 2938–2942, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. K. Sahu, P. K. Sahu, S. K. Gupta, D. Thavaselvam, and D. D. Agarwal, “Synthesis and evaluation of antimicrobial activity of 4H-pyrimido[2,1-b] benzothiazole, pyrazole and benzylidene derivatives of curcumin,” European Journal of Medicinal Chemistry, vol. 54, pp. 366–378, 2012. View at Google Scholar
  22. I. H. R. Tomi, J. H. Tomma, A. Daraji, and A. Al-Dujaili, “Synthesis, characterization and comparative study the microbial activity of some heterocyclic compounds containing oxazole and benzothiazole moieties,” Journal of Saudi Chemical Society, 2012. View at Publisher · View at Google Scholar
  23. V. S. Padalkar, B. N. Borse, V. D. Gupta et al., “Synthesis and antimicrobial activity of novel 2-substituted benzimidazole, benzoxazole and benzothiazole derivatives,” Arabian Journal of Chemistry, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Gilani, K. Nagarajan, S. P. Dixit, M. Taleuzzaman, and S. A. Khan, “Benzothiazole incorporated thiazolidin-4-ones and azetidin-2-ones derivatives: synthesis and in vitro antimicrobial evaluation,” Arabian Journal of Medicinal Chemistry, 2012. View at Publisher · View at Google Scholar
  25. M. Amir, S. Asif, I. Ali, and M. Z. Hassan, “Synthesis of benzothiazole derivatives having acetamido and carbothioamido pharmacophore as anticonvulsant agents,” Medicinal Chemistry Research, vol. 21, no. 9, pp. 2661–2670, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Kumar, B. Shrivastava, S. N. Pandeya, L. Tripathi, and J. P. Stables, “Design, synthesis, and anticonvulsant evaluation of some novel 1, 3 benzothiazol-2-yl hydrazones/acetohydrazones,” Medicinal Chemistry Research, vol. 21, no. 9, pp. 2428–2442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Navale, S. Pawar, M. Deodhar, and A. Kale, “Synthesis of substituted benzo[d]thiazol-2-ylcarbamates as potential anticonvulsants,” Medicinal Chemistry Research, vol. 22, no. 9, pp. 4316–4321, 2013. View at Publisher · View at Google Scholar
  28. P. Jimonet, F. Audiau, M. Barreau et al., “Riluzole series. Synthesis and in vivo “antiglutamate” activity of 6- substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines,” Journal of Medicinal Chemistry, vol. 42, no. 15, pp. 2828–2843, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Rana, N. Siddiqui, S. A. Khan, S. E. Haque, and M. A. Bhat, “N-{[(6-Substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: synthesis and pharmacological evaluation,” European Journal of Medicinal Chemistry, vol. 43, no. 5, pp. 1114–1122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Siddiqui, A. Rana, S. A. Khan, S. E. Haque, and M. A. Bhat, “Synthesis of benzothiazole semicarbazones as novel anticonvulsants—the role of hydrophobic domain,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 15, pp. 4178–4182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. N. D. Amnerkar and K. P. Bhusari, “Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole,” European Journal of Medicinal Chemistry, vol. 45, no. 1, pp. 149–159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Z. Hassan, S. A. Khan, and M. Amir, “Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl)amides as anticonvulsant and neuroprotective,” European Journal of Medicinal Chemistry, vol. 58, pp. 206–213, 2012. View at Publisher · View at Google Scholar
  33. V. G. Ugale, H. M. Patel, S. G. Wadodkar, S. B. Bari, A. A. Shirkhedkar, and S. J. Surana, “Quinazolino-benzothiazoles: fused pharmacophores as anticonvulsant agents,” European Journal of Medicinal Chemistry, vol. 53, pp. 107–113, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Siddiqui, S. N. Pandeya, S. A. Khan et al., “Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 1, pp. 255–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Moreno-Díaz, R. Villalobos-Molina, R. Ortiz-Andrade et al., “Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 9, pp. 2871–2877, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. V. S. Patil, K. P. Nandre, S. Ghosh et al., “Synthesis, crystal structure and antidiabetic activity of substituted (E)-3-(Benzo [d]thiazol-2-ylamino) phenylprop-2-en-1-one,” European Journal of Medicinal Chemistry, vol. 59, pp. 304–309, 2013. View at Publisher · View at Google Scholar
  37. X. Su, N. Vicker, D. Ganeshapillai et al., “Benzothiazole derivatives as novel inhibitors of human 11β- hydroxysteroid dehydrogenase type 1,” Molecular and Cellular Endocrinology, vol. 248, no. 1-2, pp. 214–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Jeon, Y. Kim, Y. Cheon, and J. Ryu, “Synthesis and biological activity of [[(heterocycloamino)alkoxy]benzyl]-2, 4-thiazolidinediones as PPARγ agonists,” Archives of Pharmacal Research, vol. 29, no. 5, pp. 394–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Ammazzalorso, A. Giancristofaro, A. D'Angelo et al., “Benzothiazole-based N-(phenylsulfonyl)amides as a novel family of PPARα antagonists,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 16, pp. 4869–4872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Navarrete-Vazquez, M. Ramírez-Martínez, S. Estrada-Soto et al., “Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors,” European Journal of Medicinal Chemistry, vol. 53, pp. 346–355, 2012. View at Google Scholar
  41. G. A. Pereira, A. C. Massabni, E. E. Castellano et al., “A broad study of two new promising antimycobacterial drugs: Ag(I) and Au(I) complexes with 2-(2-thienyl)benzothiazole,” Polyhedron, vol. 38, no. 1, pp. 291–296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. V. N. Telvekar, V. K. Bairwa, K. Satardekar, and A. Bellubi, “Novel 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives as anti-tubercular agents,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 1, pp. 649–652, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Katz, “Antituberculous compounds. III. Benzothiazole and benzoxazole derivatives,” Journal of the American Chemical Society, vol. 75, no. 3, pp. 712–714, 1953. View at Google Scholar · View at Scopus
  44. Y. Cho, T. R. Ioerger, and J. C. Sacchettini, “Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening,” Journal of Medicinal Chemistry, vol. 51, no. 19, pp. 5984–5992, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. R. Nagarajan, G. A. De Crescenzo, D. P. Getman et al., “Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease,” Bioorganic and Medicinal Chemistry, vol. 11, no. 22, pp. 4769–4777, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Shafi, M. M. Alam, N. Mulakayala et al., “Synthesis of novel 2-mercapto benzothiazole and 1,2,3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities,” European Journal of Medicinal Chemistry, vol. 49, pp. 324–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Geronikaki, D. Hadjipavlou-Litina, and M. Amourgianou, “Novel thiazolyl, thiazolinyl and benzothiazolyl Schiff bases as possible lipoxygenase's inhibitors and anti-inflammatory agents,” Farmaco, vol. 58, no. 7, pp. 489–495, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Delmas, A. Avellaneda, C. D. Giorgio et al., “Synthesis and antileishmanial activity of (1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives,” European Journal of Medicinal Chemistry, vol. 39, no. 8, pp. 685–690, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Tzanova, M. Gerova, O. Petrov, M. Karaivanova, and D. Bagrel, “Synthesis and antioxidant potential of novel synthetic benzophenone analogues,” European Journal of Medicinal Chemistry, vol. 44, no. 6, pp. 2724–2730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Cressier, C. Prouillac, P. Hernandez et al., “Synthesis, antioxidant properties and radioprotective effects of new benzothiazoles and thiadiazoles,” Bioorganic and Medicinal Chemistry, vol. 17, no. 14, pp. 5275–5284, 2009. View at Publisher · View at Google Scholar · View at Scopus